title: Natural anticoagulants and the liver.
abstract: The regulation of blood coagulation is dependent on a complex interplay between procoagulant, anticoagulant and fibrinolytic proteins. Most of these proteins are synthesised in the liver and their levels are altered in patients with liver disease. The liver also plays an important role in the regulation of haemostasis throughout the clearance of activated clotting factors. It is therefore not surprising that the critically balanced coagulation system is dysregulated in patients with liver disease. In moderate liver failure bleeding disorders predominate, whereas in more advanced liver disease intravascular coagulation is commonly observed and contributes to the overall dysregulation of blood coagulation. In some patients, liver disease can be primarily caused by an abnormality of the coagulation system. These patients usually have a hypercoagulable state caused by a deficiency of a component of the natural anticoagulant system. These include protein C, protein S and antithrombin III. More recently, activated protein C resistance caused by a point mutation in the Factor V gene has been identified as an important risk factor for thrombosis. In these patients the abnormal Factor V is resistant to cleavage by activated protein C resulting in ongoing uncontrolled procoagulant drive. Both hepatic and portal vein thrombosis have been reported in these patients. Appropriate management of these patients should include a thorough assessment of their natural anticoagulant proteins and exclusion of activated protein C resistance as the cause of their thrombotic disorder.
authors.affiliation: Box Hill Hospital, Department of Clinical Haematology, Victoria, Australia.
authors.forename: D J
authors.initials: DJ
authors.lastname: Castelino
authors.forename: H H
authors.initials: HH
authors.lastname: Salem
mesh_terms: D000990:Antithrombin III / Q000502:physiology; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders; D065427:Factor Xa Inhibitors; D015844:Heparin Cofactor II / Q000502:physiology; D006801:Humans; D008074:Lipoproteins / Q000502:physiology; D008099:Liver / Q000378:metabolism*; D008107:Liver Diseases / Q000097:blood*; D011486:Protein C / Q000502:physiology; D017293:Protein S / Q000502:physiology
chemical_list: D065427:Factor Xa Inhibitors; D008074:Lipoproteins; D011486:Protein C; D017293:Protein S; C051928:lipoprotein-associated coagulation inhibitor; D015844:Heparin Cofactor II; D000990:Antithrombin III